← FDA Drug Approvals (Drugs@FDA)

HYPAQUE-76

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GE HEALTHCARE · Approved 1980-07-02

Drug application

FDA Application #
ANDA086505
Application type
Abbreviated New Drug Application (Generic)
Brand name
HYPAQUE-76
Generic name
Diatrizoate Meglumine
Active ingredients
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
GE HEALTHCARE
First approval
1980-07-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown